helpline 01494 601 400


Read the latest epilepsy news from Epilepsy Society.

Retigabine link to skin and eye problems

30 April 2013

US Food and Drug Administration (FDA) issues drug safety alert regarding the epilepsy medication Potiga also called ezogabine, which is known as Trobalt or retigabine...

Call for charities to challenge stigma

18 April 2013

Public awareness of  epilepsy has changed little over the last 10 years, according to a new survey commissioned by Epilepsy Society.

Epilepsy Society's chief executive retires

12 April 2013

Epilepsy Society’s chief executive Graham Faulkner is standing down after more than a decade leading the UK's medical charity for people affected by epilepsy.

Drug trial for treatment of tuberous sclerosis

10 April 2013

A new trial is underway to see if a tumour-shrinking drug can improve the thought processes of adults with tuberous sclerosis, which can cause epilepsy.

Epilepsy gene discovery welcomed

9 April 2013

Professor Sanjay Sisodiya, Epilepsy Society’s head of genetics, welcomes the discovery of a gene associated with the most common form of epilepsy.

Concerns about benefits assessment

4 April 2013

A new report published by the Disability Benefits Consortium raises concerns about the delivery of the new Personal Independence Payment (PIP)assessment.

New epilepsy drug Fycompa (perampanel) launches

3 April 2013

Eisai launch new pharmaceutical drug Fycompa® (perampanel).

Tegretol prolonged release

3 April 2013

Information for people who are experiencing problems with their supply of the anti-epileptic drug (AED) Tegretol Prolonged Release .

Lil Wayne blames seizures on stress

2 April 2013

New Orleans rapper Lil Wayne blames his recent seizures on stress, lack of rest and overworking himself.

Hope for new epilepsy drugs

2 April 2013

Epilepsy expert Professor Ley Sander gives a cautious welcome to pioneering research which offers hope for the development of new epilepsy treatments.


Subscribe to News